Lactobacillus gasseri
Lactobacillus gasseri BNR17
BNR17 (KCTC 12650BP)
Supporting weight management and reducing abdominal fat.
Quick Overview
At a Glance
Researched Benefits
- Clinically shown to reduce visceral (deep belly) fat and waist circumference in human trials — no diet changes required.
- Supports healthy blood sugar and glucose response, making it a smart choice for metabolically focused wellness routines.
- Originally sourced from human breast milk, meaning it's naturally adapted to live and thrive in the human digestive system.
- Well tolerated at effective doses, with a strong safety record across multiple randomized controlled trials.
Usage & Application
Clinically Studied Dosage
10 Billion CFU/day (10¹⁰ CFU)
Available Forms
Researched For
Clinical Evidence
Belly Fat and Weight Loss Support from a Studied Probiotic Supplement: Lactobacillus gasseri BNR17
Not all probiotics are created equal — and Lactobacillus gasseri BNR17 has a genuinely fascinating origin story that sets it apart from the crowd. This strain was first isolated from human breast milk, which means it evolved to thrive in the human body from day one. Researchers at Bioneer Corporation in South Korea identified it as having unusually strong metabolic activity, and what followed was over a decade of dedicated study. Think of BNR17 as a tiny metabolic coach living in your gut: it talks to your fat cells, your liver, and your blood sugar system, nudging your body toward burning fat more efficiently and storing less of it in the first place. It does this partly by producing special carbohydrates called exopolysaccharides that interfere with how much sugar your intestines absorb, and partly by switching on the genes your body uses to burn fat for fuel instead of packing it away.
The most exciting place BNR17 really shines is around your midsection — specifically the stubborn, dangerous deep belly fat known as visceral adipose tissue. This is the fat that wraps around your organs, and it's the kind most strongly linked to metabolic health concerns. In double-blind, placebo-controlled human trials (the gold standard of clinical research), adults with a higher body weight who took a daily dose of BNR17 for twelve weeks experienced a significant reduction in visceral fat area and a measurable shrink in waist circumference — and they didn't have to change a single thing about their eating or exercise habits. People in the higher-dose groups saw the most pronounced results, suggesting a real dose-response relationship. Beyond belly fat, BNR17 has shown promise in supporting healthy blood sugar levels: in preclinical research, it helped improve the body's response to glucose and reduced markers associated with insulin resistance. There's also an emerging line of research suggesting BNR17 may help people dealing with diarrhea-predominant digestive discomfort, with participants in one clinical trial reporting less abdominal pain, less bloating, fewer urgent bathroom trips, and a noticeably better quality of daily life. And in exciting early research, BNR17 has been linked to improvements in muscle quality and lean body mass — suggesting its benefits may extend well beyond the scale.
From a safety standpoint, BNR17 has been remarkably well tolerated across all clinical trials, with no serious adverse effects reported even at higher doses. It's suitable for most healthy adults, and is particularly relevant for people who are managing their weight, concerned about blood sugar balance, or dealing with digestive irregularity. The strain is most commonly taken as a capsule or powder, typically once daily, and is best taken with or just before a meal to maximize gut survival. As with any supplement, if you are pregnant, breastfeeding, immunocompromised, or managing a chronic health condition, it's always wise to check in with your doctor before starting a new probiotic. Beyond its primary benefits, early research also points to intriguing secondary perks: potential antioxidant activity, support for healthy skin tone, and even bone density benefits in postmenopausal contexts — making BNR17 one of the most multi-dimensional strains currently under scientific investigation.
Common Questions
Frequently Asked Questions
Sources
Scientific References
Curated By

Clara Hayes
Lead Research Editor
Clara leads the curation and verification of microbiome research for our platform. With extensive experience in translating complex scientific literature into accessible insights, she ensures every strain profile is grounded in peer-reviewed evidence and contextual accuracy.
Medical Disclaimer
The information provided on probioticstrains.com is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Strain profiles and clinical summaries are compiled from published peer-reviewed literature. While we may evaluate or highlight specific commercial formulations, our insights are always grounded in available scientific evidence. Always consult a qualified healthcare provider before starting, changing, or stopping any supplement or health regimen.